| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.32 (Beat by $0.05) |
| EPS GAAP Actual | $0.32 (Beat by $0.05) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.29 |
| EPS GAAP Estimate | $0.29 |
| Revenue Estimate | $0.067301B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 1.07 | 8.5 | 1.04119 | 1.12267 | 1 |
| Dec 2025 | 1.34 | 6.78 | 1.34 | 1.34 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.31 | 0.0205 | 0B | NAN% | -69.23M |
| FQ2 2025 (Jun 2025) | 0.2 | -0.09 | 0.058454B | -41.66% | -10.77M |
| FQ1 2025 (Mar 2025) | 0.31 | 0.0196 | 0.054867B | 100% | -14.78M |
| FQ4 2024 (Dec 2024) | 279.19 | 279.19 | 50.14B | 99.93% | 50140M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | 0.18 | 0.18 | 0.082807B | 100% | 82.81M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 0B | -INF% | 0M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0.033388B | -43.75% | 33.39M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.29
Consensus Revenue Estimates
0.067301B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.225 | -- | 0.22182 | 0.2291 | 1 |
| FQ3 2027 (Sep 2027) | 0.25 | -- | 0.24387 | 0.25346 | 1 |
| FQ2 2027 (Jun 2027) | 0.25 | -- | 0.24387 | 0.25346 | 1 |
| FQ1 2027 (Mar 2027) | 0.25 | -- | 0.24387 | 0.25346 | 1 |
| FQ4 2026 (Dec 2026) | 0.25 | -- | 0.24264 | 0.26256 | 1 |
| FQ3 2026 (Sep 2026) | 0.26 | -19.23 | 0.25235 | 0.27306 | 1 |
| FQ2 2026 (Jun 2026) | 0.27 | 25.93 | 0.26206 | 0.28356 | 1 |
| FQ1 2026 (Mar 2026) | 0.29 | -6.9 | 0.28147 | 0.30457 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ3 2027 (Sep 2027) | 0.07B | -- | 0.06B | 0.07B | 1 |
| FQ2 2027 (Jun 2027) | 0.07B | -- | 0.06B | 0.07B | 1 |
| FQ1 2027 (Mar 2027) | 0.07B | -- | 0.06B | 0.07B | 1 |
| FQ4 2026 (Dec 2026) | 0.06B | -- | 0.06B | 0.07B | 1 |
| FQ3 2026 (Sep 2026) | 0.06B | -- | 0.06B | 0.07B | 1 |
| FQ2 2026 (Jun 2026) | 0.07B | 10.32 | 0.06B | 0.07B | 1 |
| FQ1 2026 (Mar 2026) | 0.07B | 18.48 | 0.07B | 0.07B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
1
EPS # of in-lines
3
Revenue # of Beats
3
Revenue # of Misses
3
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.2895 | 0.31 | 0.0205 | 6.61% |
| FQ2 2025 (Jun 2025) | 0.29 | 0.2 | -0.09 | -45% |
| FQ1 2025 (Mar 2025) | 0.2904 | 0.31 | 0.0196 | 6.32% |
| FQ4 2024 (Dec 2024) | 279.19 | 279.19 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.18 | 0.18 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.07B | $0B | $-69.23M | -INF% |
| FQ2 2025 (Jun 2025) | $0.07B | $0.06B | $-10.77M | -18.43% |
| FQ1 2025 (Mar 2025) | $0.07B | $0.05B | $-14.78M | -26.94% |
| FQ4 2024 (Dec 2024) | $0B | $50.14B | $50140M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0.08B | $82.81M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Dec 2023) | $0B | $0.03B | $33.39M | 100% |